Cell-Based Ciliary Neurotrophic Factor Therapy for Macular Telangiectasia Type 2
NEJM Evidence · 22.07.2025 · 4 (8)
DOI: 10.1056/evidoa2400481 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, erschienen am 22.07.2025. Verfasst von Emily Y Chew und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, MD. Hauptthemen laut MEDLINE: Ciliary Neurotrophic Factor, Retinal Telangiectasis. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, MD.
- Save Sight Institute, University of Sydney, NSW.
- Department of Ophthalmology, Duke University, Durham, NC.
- Paris Cité University, Lariboisière Hospital, Greater Paris University Hospitals.
- Moorfields Eye Hospital, Institute of Ophthalmology, University College London.
- Lions Eye Institute, University of Western Australia, Perth, WA.
Zitieren
APA
Chew, E. Y., Gillies, M., Jaffe, G. J., Gaudric, A., Egan, C., Constable, I., Clemons, T., Aaberg, T., Manning, D. C., Hohman, T. C., Bird, A., Friedlander, M., & MacTel CNTF NTMT-03 Research investigators (2025). Cell-Based Ciliary Neurotrophic Factor Therapy for Macular Telangiectasia Type 2. NEJM Evidence, 4(8). https://doi.org/10.1056/evidoa2400481
Vancouver
Chew EY, Gillies M, Jaffe GJ, Gaudric A, Egan C, Constable I, et al. Cell-Based Ciliary Neurotrophic Factor Therapy for Macular Telangiectasia Type 2. NEJM Evidence. 2025;4(8). doi:10.1056/evidoa2400481
BibTeX
@article{Chew2025,
author = {Chew, Emily Y and Gillies, Mark and Jaffe, Glenn J and Gaudric, Alain and Egan, Cathy and Constable, Ian and Clemons, Traci and Aaberg, Thomas and Manning, Debora C and Hohman, Thomas C and Bird, Alan and Friedlander, Martin and MacTel CNTF NTMT-03 Research investigators, MacTel CNTF NTMT-03 Research investigators},
title = {Cell-Based Ciliary Neurotrophic Factor Therapy for Macular Telangiectasia Type 2},
journal = {NEJM Evidence},
year = {2025},
volume = {4},
number = {8},
doi = {10.1056/evidoa2400481}
}
EUVIMED